Literature DB >> 4593612

Serum migration-inhibitory activity in patients with lymphoproliferative diseases.

S Cohen, B Fisher, T Yoshida, R E Bettigole.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4593612     DOI: 10.1056/NEJM197404182901605

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.

Authors:  T Yoshida; P Bigazzi; S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis.

Authors:  W Sheremata; H Triller; J B Cosgrove; E H Eylar
Journal:  Can Med Assoc J       Date:  1977-05-07       Impact factor: 8.262

Review 3.  Hodgkin's disease and anergy.

Authors:  T A Shiftan; J Mendelsohn
Journal:  Blut       Date:  1979-01-22

Review 4.  The role of cell-mediated immunity in the induction of inflammatory responses. Parke-Davis Award Lecture, 1977.

Authors:  S Cohen
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

5.  Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.

Authors:  A J Górski; B Dupont; J A Hansen; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

6.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

7.  Absence of leukocyte-migration inhibitory factor in serum from patients with mycosis fungoides.

Authors:  H Thulin
Journal:  Arch Dermatol Res       Date:  1976-12-15       Impact factor: 3.017

8.  Rosette-increasing factor (RIF) generated in vivo following PHA skin test.

Authors:  M Kubota; H Mikawa
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

9.  Generation of macrophage migration inhibitory activity by plasminogen activators.

Authors:  R O Roblin; M E Hammond; N D Bensky; A M Dvorak; H F Dvorak; P H Black
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  [Cell mediated immunity in cervical cancer patients: evaluation by in vitro leukocyte-migration-inhibition-assay (author's transl)].

Authors:  U D Koenig
Journal:  Arch Gynecol       Date:  1978-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.